Omar Wever-Pinzon

Omar Wever-Pinzon, MD, FACC

Languages spoken: English, Spanish

Academic Information

Departments Adjunct - Internal Medicine

Divisions: Cardiovascular Medicine

Board Certification

  • Educational Commission for Foreign Medical Graduates
  • American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)

Dr. Wever-Pinzon is an Associate Professor of Medicine and is the Cardiac Director, Hypertrophic Cardiomyopathy Program Center of Excellence. He received his medical degree from the University of Panama. Dr. Wever-Pinzon completed his Internal Medicine Residency, followed by a fellowship in Advanced Cardiac Imaging at St. Luke’s-Roosevelt Hospital Center-University Hospital of Columbia University College of Physicians and Surgeons in New York City. In 2010, he joined the Cardiology Investigator track at the University of Utah in Salt Lake City, where he completed his training in Cardiovascular Disease. In 2015, he completed his training in Advanced Heart Failure and Transplant Cardiology at the New York Presbyterian Hospital-Columbia University Medical Center in New York City.

Dr. Wever-Pinzon's primary clinical and academic interests are focused on the development of the Hypertrophic Cardiomyopathy Program at the University of Utah. The goals of this program are to improve the clinical management of patients with this unique condition and to advance the understanding of this inherited cardiac disease through collaborative research efforts.

Education History

Professional Medical Universidad de Panamá
 MD
Internship Hospital Santo Tomas
 Transitional Internship
Internship Aquilino Tejeira Hospital
 Transitional Internship
Residency St. Luke¿s-Roosevelt Hospital Center, Columbia University College of Physicians & Surgeons
 Resident
Fellowship St. Luke¿s-Roosevelt Hospital Center, Columbia University College of Physicians & Surgeons
 Advanced Fellow
Fellowship University of Utah
 Fellow
Research Fellow University of Utah
 Postdoctoral Fellow
Fellowship New York Presbyterian Hospital-Columbia University Medical Center
 Advanced Fellow
Postdoctoral Fellowship University of Utah
 Postdoctoral Scholar

Selected Publications

Journal Article

  1. Yao SS, Wever-Pinzon O, Zhang X, Bangalore S, Chaudhry FA (2012). Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol, 109(2), 153-8.
  2. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, Bangalore S (2012). Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol, 110(3), 383-91.
  3. Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH (2011). Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med, 124(2), 128-35.
  4. Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, Mancini DM, Colombo P, Topkara VK (2016). National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. J Heart Lung Transplant, 35(7), 884-92.
  5. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30.
  6. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, Selzman CH, Fang JC, Lund LH, Stehlik J (2017). Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant, 36(4), 407-417.
  7. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. The Journal of heart and lung transplantation, 38(8), 858-869.
  8. Pan S, Aksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, Fried JA, Takeda K, Hiroo T, Yuzefpolskaya M, Uriel N, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara V (2015). Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database. The Journal of heart and lung transplantation, 34(12), 1624-9.
  9. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu E (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR in biomedicine, 27(11), 1378-86.
  10. Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader (2018). Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation. ASAIO journal (American Society for Artificial Internal Organs, 64(1), 38-42.
  11. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson R (2020). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO journal (American Society for Artificial Internal Organs, 66(3), 291-299.
  12. Alvarez Villela M, Wever-Pinzon O, Parikh M, Deru K, Muhlestein JB, Anderson JL, Weaver L (2020). Patterns of cardiac dysfunction after carbon monoxide poisoning. Undersea & hyperbaric medicine, 47(3), 477-485.
  13. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?. Circulation, 127(4), 452-62.
  14. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos S (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274.
  15. Romero J, Husain SA, Holmes AA, Kelesidis I, Chavez P, Mojadidi MK, Levsky JM, Wever-Pinzon O, Taub C, Makani H, Travin MI, Pina IL, Garcia M (2015). Non-invasive assessment of low risk acute chest pain in the emergency department: A comparative meta-analysis of prospective studies. International journal of cardiology, 187, 565-80.
  16. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury A (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. Journal of the American College of Cardiology, 61(19), 1985-94.
  17. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Pina IL, Kfoury AG, Garcia MJ, Stehlik (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. Journal of the American College of Cardiology, 63(19), 1992-2004.
  18. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos S (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. Journal of the American College of Cardiology, 64(15), 1602-12.
  19. Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman C (2016). Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. Journal of the American College of Cardiology, 68(14), 1540-53.
  20. Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos S (2016). Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. Journal of the American College of Cardiology, 68(16), 1741-1752.
  21. Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner S (2020). Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 75(21), 2649-2660.
  22. Wever-Pinzon O, Fang JC (2019). Characterization of Sympathetic Innervation in Heart Failure With Preserved Ejection Fraction. Journal of cardiac failure, 25(4), 314-315.
  23. Supariwala A, Uretsky S, Singh P, Memon S, Khokhar SS, Wever-Pinzon O, Atluri P, Hersh J, Koppuravuri HK, Rozanski (2011). Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies. Journal of nuclear cardiology, 18(2), 207-14; quiz 217.
  24. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos S (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheterization and cardiovascular interventions, 98(7), 1275-1284.
  25. Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos S (2018). Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support. European journal of heart failure, 20(1), 164-174.
  26. Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, Wende AR, Wever-Pinzon (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. American journal of physiology. Heart and circulatory physiology, 317(4), H674-H684.
  27. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. American journal of transplantation, 11(12), 2755-61.
  28. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos S (2020). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart, lung & circulation, 29(8), 1226-1233.
  29. Wever-Pinzon O, Bangalore S, Romero J, Silva Enciso J, Chaudhry F (2011). Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study. JACC. Cardiovascular imaging, 4(12), 1231-8.
  30. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circulation. Heart failure, 6(3), 517-26.
  31. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos S (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circulation. Heart failure, 140(1), 98-100.
  32. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon (2018). Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circulation. Heart failure, 11(11), e005267.
  33. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circulation. Heart failure, 11(8), e004759.
  34. Zuñiga Cisneros J, Stehlik J, Selzman CH, Drakos SG, McKellar SH, Wever-Pinzon (2018). Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. Circulation. Heart failure, 11(3), e004378.
  35. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos S (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circulation. Heart failure, 12(8), e006085.
  36. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos S (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circulation. Heart failure, 14(5), e007991.
  37. Wever Pinzon O, Silva Enciso J, Romero J, Makani H, Fefer J, Gandhi V, Bangalore S, Chaudhry F (2011). Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography. Circulation. Cardiovascular imaging, 4(4), 363-70.
  38. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos S (2018). Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circulation. Cardiovascular imaging, 11(4), e007117.
  39. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo (2021). Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nature communications, 12(1), 873.
  40. Wever-Pinzon O, Suma V, Ahuja A, Romero J, Sareen N, Henry SA, De Benedetti Zunino M, Chaudhry FF, Suryadevara RS, Sherrid MV, Chaudhry F (2012). Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. European heart journal. Cardiovascular Imaging, 13(10), 857-62.
  41. Romero J, Kahan J, Kelesidis I, Makani H, Wever-Pinzon O, Medina H, Garcia M (2013). CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials. European heart journal. Cardiovascular Imaging, 14(11), 1080-91.
  42. Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos S (2016). Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow. JACC. Heart failure, 4(7), 570-576.
  43. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon (2020). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC. Heart failure, 8(4), 302-312.
  44. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik (2021). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA cardiology, 6(8), 957-962.
  45. Shah P, Yuzefpolskaya M, Hickey GW, Breathett K, Wever-Pinzon O, Khue-Ton V, Hiesinger W, Koehl D, Kirklin JK, Cantor RS, Jacobs JP, Habib RH, Pagani FD, Goldstein D (2022). Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device. The Annals of thoracic surgery,
  46. Sherrid MV, Swistel DG, Olivotto I, Pieroni M, Wever-Pinzon O, Riedy K, Bach RG, Husaini M, Cresci S, Reyentovich A, Massera D, Maron MS, Maron BJ, Kim (2021). Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy. Journal of the American Heart Association, 10(20), e021141.
  47. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424.
  48. Kim PJ, Olymbios M, Siu A, Wever Pinzon O, Adler E, Liang N, Swenerton R, Sternberg J, Kaur N, Ahmed E, Chen YA, Fehringer G, Demko ZP, Billings PR, Stehlik (2022). A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation. The Journal of heart and lung transplantation, 41(7), 919-927.
  49. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos S (2022). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. Journal of the American College of Cardiology, 79(9), 900-913.
  50. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos S (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circulation. Heart failure, 15(6), e008706.

Review

  1. Sherrid MV, Wever-Pinzon O, Shah A, Chaudhry F (2009). Reflections of inflections in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 54(3), 212-9.
  2. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos S (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacology & therapeutics, 134(2), 189-99.
  3. Movsesian M, Wever-Pinzon O, Vandeput (2011). PDE3 inhibition in dilated cardiomyopathy. Current opinion in pharmacology, 11(6), 707-13.
  4. Wever-Pinzon OE, Myerson M, Sherrid M (2009). Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities. Anadolu kardiyoloji dergisi, 9 Suppl 2, 17-23.
  5. Wever-Pinzon O, Drakos SG, Fang J (2015). Team-based Care for Advanced Heart Failure. Heart failure clinics, 11(3), 467-77.
  6. Tseliou E, Lavine KJ, Wever-Pinzon O, Topkara VK, Meyns B, Adachi I, Zimpfer D, Birks EJ, Burkhoff D, Drakos S (2022). Biology of myocardial recovery in advanced heart failure with long-term mechanical support. The Journal of heart and lung transplantation, 41(10), 1309-1323.

Book Chapter

  1. Wever Pinzon O, Chaudhry F (2011). Stress Echocardiography. 193-209.
  2. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos S (2013). Mechanical Unloading and Heart Remodeling Features. 413-8.
  3. Wever-Pinzon O, Fang JC (2016). Heart Failure. 941-953.

Case Report

  1. Wever-Pinzon O, Givens RC, Flannery M, Naka Y, Jorde UP (2015). Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon. J Heart Lung Transplant, 34(2), 270-1.
  2. Bukharovich IF, Wever-Pinzon O, Shah A, Todd G, Chaudhry FA, Sherrid M (2012). Arterial embolism caused by large mobile aortic thrombus in the absence of atherosclerosis, associated with iron deficiency anemia. Echocardiography (Mount Kisco, N.Y.), 29(3), 369-72.
  3. Wever-Pinzon O, Wever-Pinzon J, Tami (2011). Recurrent Takotsubo cardiomyopathy presenting with different morphologic patterns. International journal of cardiology, 148(3), 379-81.
  4. Wever-Pinzon O, Romero J, Cordova J (2013). Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy. American journal of therapeutics, 20(5), 588-90.
  5. Wever-Pinzon O, Tami (2010). Takotsubo cardiomyopathy following a blood transfusion. Congestive heart failure (Greenwich, Conn.), 16(3), 129-31.
  6. Nativi-Nicolau J, Stehlik J, Kelkhoff AJ, Khong B, Truax CM, Revelo MP, Gilbert EM, Drakos S, Wever-Pinzon O, Fang J, Catino A, Khong H (2022). Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. Transplantation proceedings, 54(1), 193-196.

Editorial

  1. Hydren JR, Richardson RS, Wever-Pinzon O, Drakos S (2020). The "double whammy" of a continuous-flow left ventricular assist device on von Willebrand factor. The Journal of thoracic and cardiovascular surgery, 159(3), 910-915.
  2. Fang JC, Wever-Pinzon (2016). Dealing With Unintended Consequences: Continuous-Flow LVADs and Aortic Insufficiency. JACC. Cardiovascular imaging, 9(6), 652-4.
  3. Wever-Pinzon O, Drakos S (2016). The Continuing Quest to Identify Ambulatory Patients With Advanced Heart Failure Who Benefit From Left Ventricular Assist Device Therapy. Circulation. Heart failure, 9(11),
  4. Stehlik J, Wever-Pinzon (2017). The Heart Transplant Waiting List and the Interplay of Policy and Practice: In Search of Fairness.LID - e004657 [pii]LID - 10.1161/CIRCHEARTFAILURE.117.004657 [doi]. Circulation. Heart failure, 10(12),
  5. Fang JC, Wever-Pinzon (2022). Allograft Rejection Surveillance In Heart Transplantation: Is There a Better Way?. Circulation, 145(25), 1825-1828.

Letter

  1. Wever-Pinzon O, Jorde UP (2014). Early power elevations and adverse events with the HeartMate II left ventricular assist device: An unsettled issue. [Letter to the editor]. J Heart Lung Transplant, 33(11), 1200-1.
  2. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos S (2013). Reply: left ventricular assist devices in chronic heart failure: more questions than answers?. Journal of the American College of Cardiology, 62(23), 2257-8.

Abstract

  1. Miller DV, Kfoury AG, Snow GL, Revelo M, Lal A, Stehlik J, McKellar SH, Fang JC, Caine W, Ashfar K, Drakos SG, Wever-Pinzon O, Molina KM, Hammond MH. (2016). Histologic Features of Mixed Rejection in Heart Transplantation: More Than Just Cellular + Antibody-Mediated Rejection? [Abstract]. J Heart Lung Transplant, 35(4), S107.
  2. Tabachnick D, Stehlik J, Gilbert E, Nativi-Nicolau J, Fang J, Wever-Pinzon O, Drakos S, Budge D, Kfoury B, Alharethi R, Caine W, Selzman C, McKellar S. (2016). Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties. [Abstract]. J Heart Lung Transplant, 35(4), S211.
  3. Ferrin P, McCreath L, Diakos N, Navankasattusas S, Kfoury AG, Wever-Pinzon O, Al-Sarie M, Catino A, Bonios M, Alharethi R, Russell G, Ragnhildstveit A, Skedros K, Hammond EH, Li DY, Selzman CH, Caine W, Stehlik J, Drakos SG. (2016). Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response. [Abstract]. J Heart Lung Transplant.
  4. Ko B, Tandar A, Kang T, McKellar S, Stehlik J, Stoddard G, Morshedzadeh J, Koliopoulou A, Gilbert E, Nativi-Nicolau J, Wever-Pinzon O, Fang J, Selzman C, Welt F, Drakos S. (2016). Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock. [Abstract]. J Heart Lung Transplant, 35(4), S278-279.
  5. Diakos N, Navankasattusas S, McKellar SH, Kfoury AG, Ferrin P, McCreath L, Miller D, Wright S, Skedros K, Al-Sari M, Ragnhildstveit A, Wever-Pinzon O, Russel G, Koliopoulou A, Reid B, Stehlik J, Selzman CH, Drakos S (2016). Changes in Metabolic Substrate Utilization and Pyruvate Mitochondrial Oxidation Mismatch during Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. The Journal of heart and lung transplantation, 35(4), S56-57.
  6. Wever-Pinzon J, Wever-Pinzon O, Mckellar S, Badger C, Fang J, Drakos S, Gilbert E, Everitt M, Alharethi R, Budge D, Stehlik J, Kfoury A, Selzman C, Nativi-Nicolau (2014). A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices. The Journal of heart and lung transplantation, 32(4S), S22.
  7. Willis C, Eckels D, Wever-Pinzon O, Kfoury A, Drakos SG, Alharethi R, Nativi Nicolau J, Budge D, Fang JC, Gilbert EM, Selzman CH, Stehlik (2014). Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization?. The Journal of heart and lung transplantation, 32(4S), S100.
  8. Kang T, Ko B, Drakos SG, Stehlik J, Gilbert EM, Nativi-Nicolau J, Wever-Pinzon O, Fang JC, Koliopoulou A, Bott SI, Tonna JE, Selzman CH, McKellar SH (2016). Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices. The Journal of heart and lung transplantation, 35(4), S392-393.
  9. Biscotti M, Wever-Pinzon O, Yuzefpolskaya M, Takayama M, Naka Y, Rosenzweig EB, Bacchetta M (2015). Partial Pulmonary-Right heart Oxygenator (PROxy) Support System: A Novel Strategy for Management of Severe Pulmonary Hypertension. The Journal of heart and lung transplantation,
  10. Levin AP, Fried J, Wever-Pinzon O, Garan AR, Takeda K, Takayama H, Yuzefpolskaya M, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK (2015). Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure. The Journal of heart and lung transplantation,
  11. Fried J, Cagliostro B, Levin A, Wever-Pinzon O, Garan AR, Te-Frey R, Ronquillo KO, Takeda K, Takayama H, Yuzefpolskaya M, Mancini DM, Naka Y, Colombo PC, Topkara V (2015). Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients. The Journal of heart and lung transplantation,
  12. Wever-Pinzon J, Al-Sarie M, Catino A, McCubrey R, Stehlik J, Kfoury A, Reid B, Wever-Pinzon O, Alharethi R, Wright S, Li D, Gilbert E, Mckellar S, Barney J, Fang J, Selzman C, Drakos S (2015). Structural and Functional Myocardial Improvement Following Continuous-Flow Mechanical Unloading in Chronic Ischemic and Non-Ischemic Cardiomyopathy. The Journal of heart and lung transplantation, 34(4), S126-127.
  13. Revelo M, Hammond EH, Stehlik J, Alharethi R, Reid B, Drakos S, Selzman C, Afshar K, Wever-Pinzon O, McKellar S, Kfoury AG, Miller DV (2017). Ultrastructural Alterations in Explanted Failed Cardiac Allografts: Insights into "Chronic Rejection". The Journal of heart and lung transplantation, 36(4), S446-447.
  14. Wever-Pinzon O, Drakos SG, McKellar SH, Koliopoulou A, Stehlik J, Selzman CH (2016). LVAD Explantation for Cardiac Recovery: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support. The Journal of heart and lung transplantation, 35(4), S11.
  15. McCreath L, Drakos SG, Ferrin P, Diakos N, Navankasattusas S, Javan H, Budge D, McKellar SH, Caine WT, Wever-Pinzon O, Bonios M, Skedros K, Ragnhildstveit A, Afshar K, Li DY, Stehlik J, Kfoury AG, Selzman CH (2016). Association of Pre-Implant Inflammatory Profile and Functional Recovery with Chronic LVAD Unloading. J Heart Lung Transplant. The Journal of heart and lung transplantation, 35(4), S11-12.
  16. Diakos N, Yen C, Wever-Pinzon O, Selzman C, Reid B, Stehlik J, Koufry A, Alharethi R, Nativi J, Catino A, Davis C, Barney J, Wright S, Koliopoulou A, Fang J, Li D, Drakos S (2014). TNF as a Predictor of Myocardial Functional Improvement Induced By Left Ventricular Mechanical Unloading. The Journal of heart and lung transplantation,
  17. Diakos N, Barney J, Yen C, Stehlik J, Koufry A, Selzman C, Reid B, Wever-Pinzon O, Saidi A, Wright S, Koliopoulou A, Russell G, McCreath L, Fang J, Li D, Drakos (2014). Structural Remodeling of the Cardiac Ventricles: When Left Isn't Equally Right. The Journal of heart and lung transplantation,
  18. Galenko O, Kfoury AG, Yen C, Selzman CH, Stehlik J, Diakos N, Wever-Pinzon O, Reid BB, Peterson H, Knight S, Alharethi R, Budge D, Nativi-Nicolau J, McKellar S, Li DY, Carlquist JC, Drakos SG (2014). Circulating Levels of miR-15b and miR-133b in Patients during Chronic LVAD Unloading. The Journal of heart and lung transplantation,
  19. Wever-Pinzon O, Farr M, Naka Y, Takayama H, George I, Colombo P, Mancini D, Schulze P (2015). Effect of the 2006 U.S. Donor Heart Allocation Policy Change on Waitlist Complications and Post-Transplant Mortality Among Candidates Supported with Mechanical Circulatory Support. The Journal of heart and lung transplantation,
  20. Wever-Pinzon O, Levin AP, Fried J, Garan AR, Takeda K, Takayama H, Yuzefpolskaya M, Mancini D, Naka Y, Colombo P, Topkara VK (2015). Effect Of Device Thrombosis And Malfunction On Clinical Outcomes Of Patients Bridging With Continuous-Flow LVADs. The Journal of heart and lung transplantation,
  21. Nativi-Nicolau J, Jaramillo Morales J, Whipple M, Al-Dulaimi R, Stehlik J, Ryan J, Drakos S, Gilbert EMM, Wever-Pinzon O, Wilson B, Han F, Maurer MS, Fang J (2016). Amyloidosis Cardiomyopathy Demonstrates Distinct Echocardiographic Patterns Compared to Patients with Heart Failure with Preserved Ejection Fraction. 22(8S), S50.

Other

  1. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo (2022). Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nature communications, 13(1), 7026.